The Toronto Star
VANCOUVER – The maker of a hormone replacement drug that’s been blamed for higher rates of breast cancer has lost its bid to block a B.C. class-action lawsuit.
The Supreme Court of Canada on Thursday declined to hear an appeal from Wyeth-Ayerst International, which makes the drugs Premarin and Premplus.
Hundreds of B.C. women claim they got breast cancer after taking the medication to ease symptoms of menopause, such as hot flashes and night sweats.
Read More: http://www.cbc.ca/cp/health/VG2885.html